QuiVad

Home / Belgium / Oxurion

Oxurion

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 13.57% on December 12, 2013. The shaded band is the year shown above.

January 7, 2013 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

178 disclosures on record for this share.
DateFund% of capitalEnd of publication
April 28, 2014Partner Fund Management, L.P.1.02%April 29, 2014
April 25, 2014Perceptive Advisors LLC4.69%April 29, 2014
April 25, 2014Orbimed Advisors LLC1.60%June 30, 2014
April 25, 2014Partner Fund Management, L.P.0.91%April 28, 2014
April 24, 2014Millennium Internation Management LP0.79%May 14, 2014
April 17, 2014Perceptive Advisors LLC4.39%April 25, 2014
April 4, 2014Falcon Edge Capital LP0.54%April 7, 2014
April 3, 2014Falcon Edge Capital LP1.15%April 4, 2014
March 31, 2014Millennium Internation Management LP0.89%April 24, 2014
March 31, 2014Partner Fund Management, L.P.0.80%April 25, 2014
March 28, 2014Millennium Internation Management LP0.97%March 31, 2014
March 28, 2014Partner Fund Management, L.P.0.77%March 31, 2014
March 27, 2014Partner Fund Management, L.P.0.61%March 28, 2014
March 19, 2014Millennium Internation Management LP1.10%March 28, 2014
March 18, 2014Millennium Internation Management LP0.81%March 19, 2014
February 28, 2014Adage Capital Management L.P.2.89%May 8, 2014
February 27, 2014Orbimed Advisors LLC1.55%April 25, 2014
February 24, 2014Millennium Internation Management LP0.73%March 18, 2014
December 20, 2013Perceptive Advisors LLC4.05%April 17, 2014
December 19, 2013Falcon Edge Capital LP2.57%April 3, 2014
December 13, 2013Meditor Capital Management Limited0.99%December 18, 2013
December 12, 2013D.E. Shaw & CO. L.P.0.61%December 19, 2013
December 5, 2013Millennium Internation Management LP0.80%February 24, 2014
December 3, 2013Falcon Edge Capital LP2.33%December 19, 2013
December 3, 2013Millennium Internation Management LP0.77%December 5, 2013
December 2, 2013Falcon Edge Capital LP2.22%December 3, 2013
November 29, 2013Perceptive Advisors LLC4.96%December 20, 2013
November 29, 2013Falcon Edge Capital LP2.03%December 2, 2013
November 28, 2013Falcon Edge Capital LP1.92%November 29, 2013
November 18, 2013Falcon Edge Capital LP1.85%November 28, 2013
November 13, 2013Perceptive Advisors LLC4.84%November 29, 2013
November 13, 2013Falcon Edge Capital LP1.40%November 18, 2013
November 8, 2013Perceptive Advisors LLC4.77%November 13, 2013
November 8, 2013Falcon Edge Capital LP1.22%November 13, 2013
November 8, 2013Meditor Capital Management Limited1.06%December 13, 2013
November 7, 2013Falcon Edge Capital LP0.57%November 8, 2013
November 6, 2013Millennium Internation Management LP0.87%December 3, 2013
November 1, 2013Perceptive Advisors LLC4.64%November 8, 2013
October 30, 2013Perceptive Advisors LLC4.59%November 1, 2013
October 28, 2013Adage Capital Management L.P.2.61%February 28, 2014
October 28, 2013Millennium Internation Management LP0.91%November 6, 2013
October 21, 2013Millennium Internation Management LP0.89%October 28, 2013
October 18, 2013Adage Capital Management L.P.2.54%October 28, 2013
October 18, 2013Millennium Internation Management LP0.90%October 21, 2013
October 9, 2013Perceptive Advisors LLC4.33%October 30, 2013
October 3, 2013Perceptive Advisors LLC4.25%October 9, 2013
October 2, 2013Perceptive Advisors LLC4.16%October 3, 2013
October 2, 2013Millennium Internation Management LP0.83%October 18, 2013
October 1, 2013Partner Fund Management, L.P.0.53%October 2, 2013
September 30, 2013Partner Fund Management, L.P.0.76%October 1, 2013

Other companies sold short in Belgium

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oxurion, source FSMA, data as at January 25, 2016, https://www.quivad.com/action/oxurion?page=2